Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 456

Is this the real life or is this just fantasy?

From time-to-time equity markets are enveloped by short-term irrationality and aspirational future cash flows. While some investors embrace this fantasy world, others choose to keep their feet on the ground.

I’ve likened this situation to The Matrix, the film in which people were offered the choice between taking a blue pill or a red pill.

The blue pill effectively plugged them into this sort of fantasy machine-led world. The red pill would reveal the truth and what’s occurring in the real world.

Today we have blue pill investors and red pill investors. The question is which investor do you want managing your money?

Blue pill investors

These investors at the forefront of market irrationality have been driven by various forces, including:

  • Historically low rates – you can’t get yield on bonds; you can’t get yield on cash in the bank.
  • A belief that central banks will remain all powerful and they’d keep buying bonds forever and keep interest rates incredibly low.
  • The rise of passive machine-led investing, which sees capital blindly flow into the biggest stocks in an index, regardless of fundamentals and valuations.

In this context, market disruption, trends and stories become even more of a drawcard. Growth stocks are all the rage. Especially small and microcaps. Afterall, there are few other options.

In this environment, the market went, what I call upside-down – it inverted. With rates being extraordinarily low, blue pill investors chased hyperbolic returns.

Case in point - the graph below. It summarises the ASX small and microcap universe of stocks between $50 million and $3 billion in market cap. It shows what would've happened if you bought a portfolio equally weighted of stocks that had negative operating cash flow from September of 2019.

Source: Bloomberg, as at 28th February 2022. Australian listed stocks between $50m and $3bn market cap divided into positive op cash flow and negative op cash flow as at 1/1/2019. Average returns measured across basket of stocks.

You can see that perversely, negative operating cash flow companies (blue line) materially outperformed positive operating cashflow companies on average over that period of time.

This is the blue pill fantasy world that we’ve experienced in recent years.

But as history tells us, it won’t last forever. The stock market can be irrational short term, but in the long run, we have found that the laws of economics, a little like gravity are hard to escape. We think the market is actually very rational in allocating capital over time.

Red pill investors

Also in the above chart, you can see the curve does come down towards the end of the period. We are starting to see negative cash flow operating companies pulling back as rates tick up and people wake up to the fact that inflation is likely here to stay.

A rising interest rate environment also sees the cost of capital rise and a “risk off” environment emerge. This is what happens in the real world.

While blue pill investors have dominated markets in recent years, red pill investors realised that for a long period of time, capital has been very cheap and the way capital has been allocated (by both companies themselves and investors) has perhaps been a little loose. They stuck to fundamentals and never forgot that valuations matter. All the while, as blue pill investors dominated markets, red pill investors were presented with an abundance of opportunity.

Now a critical juncture is emerging. Rising interest rates have a flow on effect that means cash burning companies are actually becoming more costly to hold. With interest rates on the rise this does tend to lead people back to the notion that cash is actually worth more today than tomorrow.

Disciplined red pill investors always focus on sustainable free cashflow and look at numbers through the cycle.

Long term investors would have seen all types of stocks go through cycles. We like the idea of trying to smooth out aggressively over-earning companies and not punishing companies that are temporarily under-performing on a short-term basis. This is the reason we look at ‘through the cycle’ cash flows and earnings.

Furthermore, we like to buy stocks that have low debt levels. Why? With rates rising, the cost of debt is increasing, and this puts pressure on the earnings of these companies with massive amounts of debt on the balance sheet. Additionally, we are trying to buy stocks at a discounted valuation. We try to value the stock on a mid-cycle basis and pick these stocks up at a decent discount.

And the final point is that we do keep an open mind for inflection points and changes in a company’s strategy or management teams.

A red pill stock idea

Michael Hill (ASX:MHJ) is one of our key portfolio holdings and one we think is a great illustration of long-term red-pill thinking.

It is a specialty jewelry retailer with operations in Australia, New Zealand and Canada, with a 40-year-plus track record. It is also a company that has been completely ignored in recent years by blue pill thinkers who favoured hot tech companies and concept stocks.

However, the graph below demonstrates some of the reason why we think it is a compelling opportunity for red pill investors.

Source: Morningstar, IRESS, Spheria

By looking at cash flow conversion (left graph) you can see how much of the earnings reported on an accounting basis that transfers into cashflow.

Additionally, we look at return on capital metrics (right graph). If earnings are growing on a fixed cost base and fixed capital base, there’s little doubt that earnings and returns will improve over time.

Current CEO, Daniel Bracken was hired several years ago. Since joining Michael Hill, Daniel has invested in technology, changed the pricing strategy, introduced a loyalty program and driven increased online sales. These changes have diversified the revenue stream and have led to dramatically improved results.

So much so that even the first half numbers just reported showed strong returns and earnings growth, despite approximately 20% of trading days being lost due to COVID lockdowns in Australia.

Investing for the long term

We believe that a focus on fundamentals and valuations will lead to long term outperformance for investors who are patient. For those caught up in irrational exuberance, they could very well find themselves caught in a capital landslide.

Ultimately, we live in the real world. And investors can’t continue to escape reality.

 

Marcus Burns is Co-founder and Portfolio Manager at Spheria Asset Management, an affiliate manager of Pinnacle Investment Management. Pinnacle is a sponsor of Firstlinks. This article is for general information purposes only and does not consider any person’s objectives, financial situation or needs, and because of that, reliance should not be placed on this information as the basis for making an investment, financial or other decision.

For more articles and papers from Pinnacle Investment Management and affiliate managers, click here.

 

  •   4 May 2022
  • 1
  •      
  •   

RELATED ARTICLES

Reporting season – expect early signs of downgrading

February reporting season is the calm before the storm

Reporting season shows companies meeting challenges

banner

Most viewed in recent weeks

Division 296: the initial moves to make before the windows close

What if the best superannuation strategy isn't about earning more, but acting before your options disappear? Several overlooked planning windows are narrowing, with consequences that can last for decades.

The retirement scorecard: how many of these questions can you answer?

From the maths of retirement, estimating spending and picking the right asset allocation to survive a poor decade, here are the questions every retiree – current or future – should be able to answer for themselves.

Testamentary trusts: Treasury has picked the wrong reading

A decades-old estate planning tool has survived one tax crackdown only to be caught by another. The surprise isn't who the reform is targeting, but who could end up paying the price for drafting choices made years ago.

Superannuation’s structural failings

Politicians are fighting over access to super, but they may be arguing about the wrong thing. The system’s three fundamental flaws have been hiding in plain sight for decades, costing Australians far more than they realise.

Avoid unnecessary CGT with this estate planning clause

A simple estate plan can create a ticking time bomb. One overlooked clause can pit spouses against children, delay inheritances, and potentially leave a family facing an unexpected tax bill worth hundreds of thousands of dollars.

Does an American retirement rule work for Australians?

The 4% rule has survived decades of scrutiny, but Australia's retirement system changes the equation in ways most overlook. Before accepting or rejecting this rule of thumb, it pays to understand what really drives retirement outcomes.

Latest Updates

Superannuation

Bill Kelty: Super can't solve everyone's problems

One of the key figures behind Australia’s superannuation system reflects on how it began, what has changed, and why some of today’s biggest debates may be asking too much of a retirement savings system.

Investment strategies

Rising yields have put bonds back in business

For the past decade, investors were forced to chase income wherever they could find it. With yields now offering competition to dividends, the new challenge is deciding whether they're still being adequately rewarded for risk.

Strategy

Do you want a bucket with that?

Retirees, advisers and super funds all talk about the bucket strategy as if it's one thing. It's not. The differences can be significant, and some may matter far more than investors realise when markets become volatile.

Investment strategies

What The Odyssey can teach us about valuation discipline

Investment temptations are hard to resist in the moment, but successful investing is not about ignoring compelling opportunities or ideas. For value investors, the smart move is to prepare before momentum clouds judgement.

Shares

Does market concentration really mean more risk for investors?

One of the most closely watched trends in global markets has become a growing source of investor concern in recent years. Whether that concern is justified, however, turns out to be a far more complicated question.

Retirement

Retirement in reality - 8 months in

Health goals, new friendships and lingering questions about identity have dominated this month. The experience has challenged widely held beliefs about purpose, belonging and what it really means to leave work behind.

Shares

Stagnation might be OK at this point

Australia's economic problems are hardly a secret. The more interesting question for investors is whether the stock market is as exposed to those problems as commonly assumed, or whether the picture is more nuanced.

Sponsors

Alliances

  • ASA-Logo-RGB-ActiveGreen-web.png

© 2026 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.